Cargando…

Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities

Aberrant DNA methylation is an epigenetic hallmark of melanoma, known to play important roles in melanoma formation and progression. Recent advances in genome-wide methylation methods have provided the means to identify differentially methylated genes, methylation signatures, and potential biomarker...

Descripción completa

Detalles Bibliográficos
Autores principales:	Micevic, Goran, Theodosakis, Nicholas, Bosenberg, Marcus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381063/ https://www.ncbi.nlm.nih.gov/pubmed/28396701 http://dx.doi.org/10.1186/s13148-017-0332-8

Ejemplares similares

Aberrant DNA Methylation as a Biomarker and a Therapeutic Target of Cholangiocarcinoma
por: Nakaoka, Toshiaki, et al.
Publicado: (2017)

Genome-wide characterization of human L1 antisense promoter-driven transcripts
por: Criscione, Steven W., et al.
Publicado: (2016)

Aberrant Sialylation in Cancer: Therapeutic Opportunities
por: Munkley, Jennifer
Publicado: (2022)

Aberrant DNA Methylation Predicts Melanoma-Specific Survival in Patients with Acral Melanoma
por: Pradhan, Dinesh, et al.
Publicado: (2019)

Decoding Melanoma Metastasis
por: Damsky, William E., et al.
Publicado: (2010)

Aberrant RNA splicing and therapeutic opportunities in cancers
por: Yamauchi, Hirofumi, et al.
Publicado: (2021)

Aberrant DNA methylation in multiple myeloma: A major obstacle or an opportunity?
por: Muylaert, Catharina, et al.
Publicado: (2022)

Aberrant DNA methylation in cervical Carcinogenesis
por: Yang, Hui-Juan
Publicado: (2013)

Aberrant DNA Methylation of ABC Transporters in Cancer
por: Zappe, Katja, et al.
Publicado: (2020)

Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities
por: De Matteis, Serena, et al.
Publicado: (2018)

DNA methylation/hydroxymethylation in melanoma
por: Fu, Siqi, et al.
Publicado: (2017)

Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities
por: Rambow, Florian, et al.
Publicado: (2019)

Histone and DNA Methylation as Epigenetic Regulators of DNA Damage Repair in Gastric Cancer and Emerging Therapeutic Opportunities
por: De Marco, Katia, et al.
Publicado: (2023)

Aberrant DNA Methylation in Keratoacanthoma
por: Nobeyama, Yoshimasa, et al.
Publicado: (2016)

DNA Methylation Aberrant in Atherosclerosis
por: Dai, Yao, et al.
Publicado: (2022)

DNA Methylation and Uveal Melanoma
por: Yang, Zhi-Kun, et al.
Publicado: (2018)

Deciphering the role of aberrant DNA methylation in NAFLD and NASH()
por: Vachher, Meenakshi, et al.
Publicado: (2022)

Field cancerization in the colon: a role for aberrant DNA methylation?
por: Luo, Yanxin, et al.
Publicado: (2014)

Inappropriate costimulation and aberrant DNA methylation as therapeutic targets in angioimmunoblastic T-cell lymphoma
por: Willemsen, Mathijs, et al.
Publicado: (2017)

IL-7R licenses a population of epigenetically poised memory CD8(+) T cells with superior antitumor efficacy that are critical for melanoma memory
por: Micevic, Goran, et al.
Publicado: (2023)

Aberrant Sialylation in Cancer: Biomarker and Potential Target for Therapeutic Intervention?
por: Pietrobono, Silvia, et al.
Publicado: (2021)

Aberrant DNA Methylation and Prostate Cancer
por: Majumdar, Sunipa, et al.
Publicado: (2011)

Aberrant DNA Methylation in ES Cells
por: Ludwig, Guy, et al.
Publicado: (2014)

DNA promoter methylation as a diagnostic and therapeutic biomarker in gallbladder cancer
por: Letelier, Pablo, et al.
Publicado: (2012)

Novel Biomarkers and Therapeutic Targets for Melanoma
por: Sabag, Noa, et al.
Publicado: (2022)

Anorectal and Genital Mucosal Melanoma: Diagnostic Challenges, Current Knowledge and Therapeutic Opportunities of Rare Melanomas
por: Ottaviano, Margaret, et al.
Publicado: (2022)

Methylated circulating tumor DNA as a biomarker in cutaneous melanoma
por: Diefenbach, Russell J, et al.
Publicado: (2020)

Distinct DNA Methylation Profiles in Ovarian Tumors: Opportunities for Novel Biomarkers
por: Losi, Lorena, et al.
Publicado: (2018)

Aberrant DNA Methylation in Acute Myeloid Leukemia and Its Clinical Implications
por: Yang, Xianwen, et al.
Publicado: (2019)

Emerging Therapeutic Opportunities Based on Current Knowledge of Uveal Melanoma Biology
por: Vivet-Noguer, Raquel, et al.
Publicado: (2019)

Aberrant Methylation of LINE-1 Transposable Elements: A Search for Cancer Biomarkers
por: Ponomaryova, Anastasia A., et al.
Publicado: (2020)

DNA repair defects in cancer and therapeutic opportunities
por: Hopkins, Jessica L., et al.
Publicado: (2022)

WNT/β-catenin signaling in hepatocellular carcinoma: The aberrant activation, pathogenic roles, and therapeutic opportunities
por: Gajos-Michniewicz, Anna, et al.
Publicado: (2023)

Aberrant DNA methylation patterns in diabetic nephropathy
por: Maghbooli, Zhila, et al.
Publicado: (2014)

Aberrant DNA methylation profile exacerbates inflammation and neurodegeneration in multiple sclerosis patients
por: Celarain, Naiara, et al.
Publicado: (2020)

DNA Methylation in Regulatory T Cell Differentiation and Function: Challenges and Opportunities
por: Bai, Lu, et al.
Publicado: (2022)

Aberrant Metabolism as Inductor of Epigenetic Changes in Breast Cancer: Therapeutic Opportunities
por: Coronel-Hernández, Jossimar, et al.
Publicado: (2021)

A New Approach to Evaluating Aberrant DNA Methylation Profiles in Hepatocellular Carcinoma as Potential Biomarkers
por: Yang, Yuan, et al.
Publicado: (2017)

Identifying prognostic biomarkers based on aberrant DNA methylation in kidney renal clear cell carcinoma
por: Chen, Guang, et al.
Publicado: (2016)

Spitz nevi and Spitzoid melanomas - Exome sequencing and comparison to conventional melanocytic nevi and melanomas
por: Lazova, Rossitza, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kc8j3449f0jd266vds9apokl1k